MiR-30a-3p Targeting FLT1 Modulates Trophoblast Cell Proliferation in the Pathogenesis of Preeclampsia
Authors:
- 18 August 2022
- journal article
- research article
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 54 (09) , 633-640
Abstract
Preeclampsia (PE) may pose significant adverse effects on pregnant women. Dysregulation of angiogenesis, trophoblast invasion, and proliferation are known to be associated with PE development and progression. Fms related tyrosine kinase 1 (FLT1), an anti-angiogenic factor, is consistently upregulated in PE patients. Recent papers highlight that aberrant miR-30a-3p expression contributes to PE development. More effects are needed to assess the biological function of placental miR-30a-3p in PE. The soluble FLT1 (sFLT1) and FLT1 levels were tested by ELISA assay and Western blotting assay. mRNA levels were measured by RT-qPCR assay. Colony formation and MTT assays were applied to assess the effect of miR-30a-3p on trophoblast cell proliferation. The serum sFLT1 and placental FLT1 levels were substantially high in patients with PE. Using miRNA microarray assay, we identified miR-30a-3p upregulation in PE patients’ placenta tissues. We further confirmed that miR-30a-3p binds to the 3′-UTR of FLT1 gene and positively regulate its expression. Forcing miR-30a-3p expression inhibited trophoblast cell proliferation and vice versa. In conclusion, persistent high levels of FLT1 and miR-30a-3p may pose adverse effects on angiogenesis and trophoblast proliferation in placenta of PE patients. Therefore, targeting FLT1 and miR-30a-3p may serve as ideal strategies for managing patients with PE.Keywords
This publication has 23 references indexed in Scilit:
- Molecular Mechanisms of PreeclampsiaCold Spring Harbor Perspectives in Medicine, 2015
- A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box regionRetrovirology, 2014
- The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesisGenes & Development, 2013
- The Role of MicroRNAs in Human Diseases2013
- MicroRNAs and other non-coding RNAs as targets for anticancer drug developmentNature Reviews Drug Discovery, 2013
- MicroRNA expression profiles in placenta with severe preeclampsia using a PNA-based microarrayPlacenta, 2013
- Preeclampsia Up-Regulates Angiogenesis-Associated MicroRNA (i.e., miR-17, -20a, and -20b) That Target Ephrin-B2 and EPHB4 in Human PlacentaThe Journal of Clinical Endocrinology & Metabolism, 2012
- Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseasesHuman Molecular Genetics, 2012
- Soluble Flt‐1 as a diagnostic marker of pre‐eclampsiaAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2008
- Growth and function of the normal human placentaThrombosis Research, 2004